ArticleBMC cancer2026

Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.